The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1487604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Sara Baroni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scient…. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Virus Replication, Lurasidone Hydrochloride. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coronaviruses (CoVs) share key genomic elements critical for viral replication, suggesting the feasibility of developing therapeutics with efficacy across different viruses. In a previous work, we demonstrated the antiviral activity of the antipsychotic drug lurasidone against both SARS-CoV-2 and HCoV-OC43. In this study, our investigations on the mechanism of action of lurasidone suggested that the drug exhibits antiviral activity by targeting the papain-like protease (PL-Pro) of both viruses, and the Spike protein of SARS-CoV-2, thereby hampering both the entry and the viral replication. In vitro assays demonstrate that lurasidone significantly reduces viral load in infected cells, showing that the drug is a promising candidate for further development as a dual-action antiviral, offering a potential new strategy in the fight against COVID-19 and other coronavirus-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milano, Italy.
- Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
- Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Regione Gonzole, Turin, Italy.
- Dipartimento di Bioscienze, Università degli Studi di Milano, Milano, Italy.
- Consiglio Nazionale delle Ricerche, Istituto di Biofisica, Milano, Italy.
- Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy.
Zitieren
APA
Baroni, S., Carletti, T., Donalisio, M., Arduino, I., Cazzaniga, I., Giorgino, T., Esposito, F., Porta, A., Diomede, L., De Luigi, A., Gobbi, M., Lembo, D., Marcello, A., Tramontano, E., Milani, M., & Mastrangelo, E. (2024). The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1487604
Vancouver
Baroni S, Carletti T, Donalisio M, Arduino I, Cazzaniga I, Giorgino T, et al. The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1487604
BibTeX
@article{Baroni2024,
author = {Baroni, Sara and Carletti, Tea and Donalisio, Manuela and Arduino, Irene and Cazzaniga, Irene and Giorgino, Toni and Esposito, Francesca and Porta, Alessia and Diomede, Luisa and De Luigi, Ada and Gobbi, Marco and Lembo, David and Marcello, Alessandro and Tramontano, Enzo and Milani, Mario and Mastrangelo, Eloise},
title = {The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1487604}
}
EUVIMED